RecruitingPhase 3NCT03083184

Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients

Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients: a mulTi-centre, Randomized, Single Blind, Parallel Group studY (ETERNITY)

Sponsor

University Hospital, Clermont-Ferrand

Enrollment

400 participants

Start Date

Feb 9, 2018

Study Type

INTERVENTIONAL

Conditions

Tunnelled Hemodialysis Catheter Infection

Summary

The purpose of this study is to assessed the efficacy of a combined solution of ethanol (4%) and low molecular weight heparins LMWH in preventing tunnelled dialysis catheter infection in chronic hemodialysis patients

Eligibility

Min Age: 18 Years

Inclusion Criteria5

end-stage renal disease
chronic hemodialysis/hemodiafiltration at least three times a week
functional TC inserted for at least two weeks
Social security cover
Written informed consent

Exclusion Criteria1

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGEthanol

An ethanol 40 % v/v - enoxaparin 1000 U/mL (Ethenox) interdialytic lock solution

DRUGenoxaparin

An ethanol 40 % v/v - enoxaparin 1000 U/mL (Ethenox) interdialytic lock solution

Locations(1)

CHU Clermont-Ferrand

Clermont-Ferrand, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03083184